| 1. One-step RT-PCR | Reverse transcription and PCR amplification take place in the same reaction tube. | An amplified target, detected in real time or at the end of the reaction, depending on the assay. | Routine workflows where fewer handling steps and reduced tube transfers are priorities. | Check that the enzyme and reaction chemistry suit the target and sample. The cDNA is generally not available for separate downstream assays. |
| 2. Two-step RT-PCR | RNA is reverse-transcribed in a separate reaction; the resulting cDNA is then used in one or more PCR reactions. | Amplification results from the selected PCR assay or assays. | Studies testing multiple targets from the same cDNA preparation or using cDNA in follow-up work. | Offers flexibility but adds handling steps and potential for contamination. Include the extra preparation time when planning workflow. |
| 3. Probe-based real-time RT-PCR | A target-specific fluorescent probe generates signal during amplification, which an instrument measures cycle by cycle. | A fluorescence amplification curve and, commonly, a Cq/Ct value for a detected target. | Target-specific detection and assays that need to distinguish multiple targets with separate fluorescent channels. | Requires a probe designed for the target. Confirm instrument channel compatibility and that the assay has been validated for the intended use. |
| 4. Dye-based real-time RT-PCR | A fluorescent dye binds double-stranded DNA, and signal is monitored as amplified DNA accumulates. | A fluorescence curve and Cq/Ct value; a melt-curve analysis may be used to assess the amplified product. | Cost-conscious, usually single-target assays where post-amplification melt analysis is appropriate. | The dye can also report nonspecific double-stranded products, so assay specificity and controls are important. It is generally less suited to multiplexing than probe-based detection. |
| 5. Multiplex real-time RT-PCR | Two or more target sequences are amplified in one reaction, typically using distinguishable fluorescent probes. | Separate signals for the included targets and, when designed, an internal control. | Testing several targets in one sample while conserving sample volume and reaction capacity. | Check the instrument’s available channels, target compatibility, and validation data. Multiplex performance can be affected by competition between reactions. |
| 6. Singleplex real-time RT-PCR | One target is measured per reaction using real-time fluorescence detection. | A target-specific amplification curve and Cq/Ct value, if the target is detected within the assay’s validated range. | Focused testing, assay development, or situations where independent target reactions are preferred. | Compare the number of reactions required per sample with a suitable multiplex option. Cq/Ct values alone are not a universal measure of RNA quantity across different assays. |
| 7. Endpoint RT-PCR | After reverse transcription and amplification, the PCR product is assessed at the end of the reaction, often by gel electrophoresis. | A visible product of an expected size or another endpoint signal; standard endpoint results are usually qualitative or semi-quantitative. | Presence-or-absence checks and applications where real-time quantification is not required. | Post-PCR handling can increase contamination risk. Endpoint signal is not equivalent to a validated quantitative RNA measurement. |
| 8. Relative-quantification RT-qPCR | Target Cq/Ct values are compared with a reference gene and a calibrator sample; methods such as ΔΔCq can estimate relative expression. | A relative expression value or fold change, rather than an absolute number of RNA copies. | Comparing gene expression between samples or experimental conditions. | Reference genes must be appropriate and stable for the samples. The calculation also relies on suitable assay performance, including comparable amplification efficiencies for common ΔΔCq use. |
| 9. Standard-curve absolute-quantification RT-qPCR | Sample Cq/Ct values are compared with a dilution series of standards with known concentrations or copy numbers. | An estimated target quantity within the range supported by the standard curve and assay validation. | Applications requiring a concentration or copy-number estimate using a defined standard and calculation method. | Standard quality, dilution accuracy, extraction recovery, and the stated reporting units affect interpretation. Results are not directly comparable across different validated methods without appropriate controls. |
| 10. Reverse-transcription digital PCR (RT-dPCR) | RNA is reverse-transcribed, and the PCR reaction is partitioned into many individual reactions. Target-positive partitions are counted and used to estimate concentration, commonly with Poisson statistics. | An absolute concentration estimate within the assay’s validated range, generally without relying on a standard curve for quantification. | Applications where partition-based counting or absolute quantification is valuable. | Assess instrument and consumable requirements, partition counts, controls, and validated limits. Reverse-transcription efficiency and sample quality still affect RNA measurements. |